Recommendations on the Use of Multiple Labels in Human Mass Balance Studies
Filip Cuyckens1, Mette G Hvenegaard2, Kenneth C Cassidy2
1Janssen R&D, Beerse, Belgium (F.C.); H. Lundbeck A/S, Copenhagen, Denmark (M.G.H.); Eli Lilly and Company, Indianapolis, Indiana (K.C.C.); Pfizer Inc., Groton, Connecticut (D.K.S.); Novartis, Basel, Switzerland (A.D.J.); Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (M.L.P.); Sosei Heptares, Cambridge, United Kingdom (G.S.); AbbVie, North Chicago, Illinois (D.S.W.); Bayer AG, Wuppertal, Germany (K.G., S.I.S.); The Healthcare Business of Merck KGaA, Darmstadt, Germany (H.S.); Novo Nordisk, Maaloev, Denmark (I.B.); Roche Pharma Research and Early Development, Basel, Switzerland (A.A.R.); Servier, Gif-sur-Yvette, France (G.Da.V.); Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany (S.B.); Sanofi, Montpellier, France (P.M.); and GSK Research & Development Ltd., Stevenage (G.C.Y.) fcuycken@its.jnj.com.
Radiolabeled drug studies are crucial for ADME. This review guides choosing single or multiple radiolabels to track drug metabolism and avoid losing data on cleaved metabolites.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Radiopharmaceutical Chemistry
Background:
- Radiolabeled drug studies are the gold standard for Absorption, Distribution, Metabolism, and Excretion (ADME) research.
- Accurate quantification of parent drugs and metabolites is essential for drug development.
- Molecular cleavage during biotransformation can lead to loss of radiolabel, hindering metabolite tracking.
Purpose of the Study:
- To provide decision criteria for selecting single versus multiple radiolabel approaches in drug metabolism studies.
- To discuss the advantages and disadvantages of various multiple-labeling strategies.
- To explore alternative methods for tracking non-labeled metabolites.
Main Methods:
- Review of existing literature and strategies for radiolabeling in drug metabolism.
- Analysis of challenges and benefits associated with single and multiple radiolabel approaches.
- Discussion of alternative analytical techniques for metabolite identification.
Main Results:
- The choice of radiolabel position is critical for obtaining relevant ADME data.
- Multiple radiolabeling strategies can address issues of metabolite cleavage but introduce complexity.
- Alternative methods exist to track non-labeled portions of drug molecules.
Conclusions:
- Careful consideration of radiolabel placement and labeling strategy is vital for comprehensive ADME studies.
- Multiple radiolabeling offers solutions for complex metabolic pathways but requires strategic planning.
- Emerging techniques may offer complementary approaches to traditional radiolabeling methods.
More Related Videos
07:41A Method for Measuring Metabolism in Sorted Subpopulations of Complex Cell Communities Using Stable Isotope Tracing
Published on: February 4, 2017
12:47Workflow Based on the Combination of Isotopic Tracer Experiments to Investigate Microbial Metabolism of Multiple Nutrient Sources
Published on: January 22, 2018
Related Concept Videos
Mass Spectrometry: Isotope Effect
Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
High-Resolution Mass Spectrometry (HRMS)
